Last reviewed · How we verify
EPC treatment group
At a glance
| Generic name | EPC treatment group |
|---|---|
| Sponsor | Allife Medical Science and Technology Co., Ltd. |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- The Family Check-Up in Autism Services (NA)
- A Clinical Study of iEPC Intervent Subjects With Cerebral Hemorrhagic Stroke (EARLY_PHASE1)
- Autologous CD133(+) Cells as an Adjuvant to Below the Knee Percutaneous Transluminal Angioplasty (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- EPC treatment group CI brief — competitive landscape report
- EPC treatment group updates RSS · CI watch RSS
- Allife Medical Science and Technology Co., Ltd. portfolio CI